🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The risk of recurrence is greatest immediately after stroke or Transient Is...
Status
Terminated
Location
Nottingham University Hospitals NHS Trust
Start Date
2009-04
Trial ID
NCT01661322
Treatments Being Tested
This research study will evaluate the effects of aspirin and dipyridamole a...
Status
Terminated
Location
Presbyterian Hospital, 51 N. 39th St.
Start Date
2002-09
Trial ID
NCT00906035
Treatments Being Tested
During sepsis and septic shock the immune response can be overwhelming lead...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2010-03
Trial ID
NCT01091571
Treatments Being Tested
The antihyperglycemic drug metformin and the thrombocyte aggregation inhibi...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2012-04
Trial ID
NCT01613755
Treatments Being Tested
Study to establish the bioequivalence of a new formulation of Asasantin ER ...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT02273531
Treatments Being Tested
There is a marked lack of evidence on the optimal prevention of ischaemic s...
Status
Completed
Location
Amsterdam UMC
Start Date
2014-09
Trial ID
NCT02565693
Treatments Being Tested
Phase III study to compare the preventive effect of recurrent brain infarct...
Status
Completed
Location
9.178.060 Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00311402
Treatments Being Tested
The purpose of the trial is to determine if extended-release dipyridamole +...
Status
Completed
Location
9.159.1101 Boehringer Ingelheim Investigational Site
Start Date
2003-08
Trial ID
NCT00153062
German stroke units are hesitating to use Aggrenox for secondary ischaemic ...
Status
Completed
Location
9.182.1 Boehringer Ingelheim Investigational Site
Start Date
2007-07
Trial ID
NCT00562588
Treatments Being Tested
The objective of this study was to compare the pharmacokinetics of dipyrida...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT02273557